Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. Juni 2021 07:35 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals to Webcast Live at Life Sciences Investor Forum

CHARLOTTESVILLE, Va., June 21, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
18. Juni 2021 07:35 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Reminds Stockholders to Vote Shares In Advance of Annual Meeting

CHARLOTTESVILLE, Va., June 18, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion,” “we” or the “Company”), an innovative biopharmaceutical company developing novel...
10. Mai 2021 07:50 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Reports Final Results from Its Phase 1b Study of Trans Sodium Crocetinate in Hospitalized COVID-19 Patients

CHARLOTTESVILLE, Va., May 10, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
10. Mai 2021 07:05 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update

CHARLOTTESVILLE, Va., May 10, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
25. März 2021 09:01 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study

CHARLOTTESVILLE, Va., March 25, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
18. März 2021 07:05 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Doses First Participants in TCOM Study

CHARLOTTESVILLE, Va., March 18, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
17. März 2021 07:05 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update

CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
04. März 2021 16:05 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

CHARLOTTESVILLE, Va., March 04, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
18. Februar 2021 16:05 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock

CHARLOTTESVILLE, Va., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
17. Februar 2021 16:13 ET | Quelle: Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock

CHARLOTTESVILLE, Va., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...

Vorherige Seite

Nächste Seite